# Examining the Therapeutic Potential of Botulinum Toxin Type A in the Treatment of Keloids

> **NCT05330078** · EARLY_PHASE1 · COMPLETED · sponsor: **University of California, San Diego** · enrollment: 10 (actual)

## Conditions studied

- Keloid

## Interventions

- **DRUG:** Botulinum toxin type A
- **DRUG:** Vehicle

## Key facts

- **NCT ID:** NCT05330078
- **Lead sponsor:** University of California, San Diego
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-11
- **Primary completion:** 2023-05-31
- **Final completion:** 2023-05-31
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2025-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05330078

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05330078, "Examining the Therapeutic Potential of Botulinum Toxin Type A in the Treatment of Keloids". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT05330078. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*